Karl Haglund

1.1k total citations
29 papers, 859 citations indexed

About

Karl Haglund is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Virology. According to data from OpenAlex, Karl Haglund has authored 29 papers receiving a total of 859 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 5 papers in Virology. Recurrent topics in Karl Haglund's work include Lung Cancer Diagnosis and Treatment (10 papers), HIV Research and Treatment (5 papers) and Advanced Radiotherapy Techniques (4 papers). Karl Haglund is often cited by papers focused on Lung Cancer Diagnosis and Treatment (10 papers), HIV Research and Treatment (5 papers) and Advanced Radiotherapy Techniques (4 papers). Karl Haglund collaborates with scholars based in United States, Czechia and Bulgaria. Karl Haglund's co-authors include John K. Rose, David A. Stayner, Larry Davidson, Akhil C. Banerjea, Changjie Chen, Manfred Schubert, George G. Harmison, Meng Xu‐Welliver, Jaak Rakfeldt and Jacob Kraemer Tebes and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Cancer.

In The Last Decade

Karl Haglund

29 papers receiving 823 citations

Peers

Karl Haglund
Dowain A. Wright United States
Clifford W. Bogue United States
Xiaoyue Ma United States
Richard Carr United Kingdom
E Zuckerman United States
Thomas V. Sedlacek United States
Eileen Scigliano United States
Dowain A. Wright United States
Karl Haglund
Citations per year, relative to Karl Haglund Karl Haglund (= 1×) peers Dowain A. Wright

Countries citing papers authored by Karl Haglund

Since Specialization
Citations

This map shows the geographic impact of Karl Haglund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Haglund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Haglund more than expected).

Fields of papers citing papers by Karl Haglund

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl Haglund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Haglund. The network helps show where Karl Haglund may publish in the future.

Co-authorship network of co-authors of Karl Haglund

This figure shows the co-authorship network connecting the top 25 collaborators of Karl Haglund. A scholar is included among the top collaborators of Karl Haglund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl Haglund. Karl Haglund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sebastian, Nikhil, Amy Webb, Konstantin Shilo, et al.. (2023). A PI3K gene expression signature predicts for recurrence in early‐stage non–small cell lung cancer treated with stereotactic body radiation therapy. Cancer. 129(24). 3971–3977. 3 indexed citations
2.
Sebastian, Nikhil, Rahul N. Prasad, C. Barney, et al.. (2020). Association of Pre- and Posttreatment Neutrophil–Lymphocyte Ratio With Recurrence and Mortality in Locally Advanced Non-Small Cell Lung Cancer. Frontiers in Oncology. 10. 598873–598873. 19 indexed citations
3.
Johns, Andrew, Desmond M. D’Souza, Terence M. Williams, et al.. (2020). Clinical Course of Hypertrophic Pulmonary Osteoarthropathy in a Patient Receiving Immune Checkpoint Inhibitor Therapy. Clinical Lung Cancer. 21(4). e243–e245. 1 indexed citations
4.
Sebastian, Nikhil, Robert E. Merritt, Mahmoud Abdel‐Rasoul, et al.. (2020). Recurrence After Stereotactic Body Radiation Therapy Versus Lobectomy for Non-Small Cell Lung Cancer. The Annals of Thoracic Surgery. 110(3). 998–1005. 8 indexed citations
5.
Sebastian, Nikhil, Trudy C. Wu, Henning Willers, et al.. (2019). Pre-treatment serum bicarbonate predicts for primary tumor control after stereotactic body radiation therapy in patients with localized non-small cell lung cancer. Radiotherapy and Oncology. 140. 26–33. 2 indexed citations
6.
Sebastian, Nikhil, Trudy C. Wu, Jose G. Bazan, et al.. (2019). Pre-treatment neutrophil-lymphocyte ratio is associated with overall mortality in localized non-small cell lung cancer treated with stereotactic body radiotherapy. Radiotherapy and Oncology. 134. 151–157. 23 indexed citations
7.
Miller, Eric D., James L. Fisher, Karl Haglund, et al.. (2018). Identifying patterns of care for elderly patients with non-surgically treated stage III non-small cell lung cancer: an analysis of the national cancer database. Radiation Oncology. 13(1). 196–196. 17 indexed citations
8.
Miller, Eric D., James L. Fisher, Karl Haglund, et al.. (2018). The Addition of Chemotherapy to Radiation Therapy Improves Survival in Elderly Patients with Stage III Non–Small Cell Lung Cancer. Journal of Thoracic Oncology. 13(3). 426–435. 49 indexed citations
9.
Pollock, Raphael E., Stephen M. Smith, O. Hans Iwenofu, et al.. (2018). Multidisciplinary sarcoma care. Current Problems in Surgery. 55(12). 517–580. 3 indexed citations
10.
Barney, C., Ahmet S. Ayan, D.J. DiCostanzo, et al.. (2017). Radiation Dose to the Thoracic Vertebral Bodies Is Associated With Acute Hematologic Toxicities in Patients Receiving Concurrent Chemoradiation for Lung Cancer: Results of a Single-Center Retrospective Analysis. International Journal of Radiation Oncology*Biology*Physics. 100(3). 748–755. 24 indexed citations
12.
Miller, Eric D., Meng Xu‐Welliver, & Karl Haglund. (2014). The role of modern radiation therapy in the management of extremity sarcomas. Journal of Surgical Oncology. 111(5). 599–603. 21 indexed citations
13.
Thomas, Anish, Sujata M. Shanbhag, Karl Haglund, et al.. (2013). Characterization and Management of Cardiac Involvement of Thymic Epithelial Tumors. Journal of Thoracic Oncology. 8(2). 246–249. 14 indexed citations
14.
Haglund, Karl, Chandrajit P. Raut, Alessandra F. Nascimento, et al.. (2010). Recurrence Patterns and Survival for Patients With Intermediate- and High-Grade Myxofibrosarcoma. International Journal of Radiation Oncology*Biology*Physics. 82(1). 361–367. 88 indexed citations
15.
Haglund, Karl & Akila N. Viswanathan. (2008). Computed Tomography–Based Radiation Therapy of Ovarian Remnants for Symptomatic Persistent Endometriosis. Obstetrics and Gynecology. 111(2). 579–583. 4 indexed citations
16.
Campanella, Thomas J. & Karl Haglund. (2003). Inventing the Charles River. The New England Quarterly. 76(1). 137–137. 4 indexed citations
17.
Davidson, Larry, Karl Haglund, David A. Stayner, et al.. (2001). "It was just realizing…that life isn't one big horror": A qualitative study of supported socialization.. Psychiatric Rehabilitation Journal. 24(3). 275–292. 110 indexed citations
19.
Rolls, Melissa M., Karl Haglund, & John K. Rose. (1996). Expression of Additional Genes in a Vector Derived from a Minimal RNA Virus. Virology. 218(2). 406–411. 20 indexed citations
20.
Chen, Changjie, Akhil C. Banerjea, George G. Harmison, Karl Haglund, & Manfred Schubert. (1992). Multitarget-ribozyme directed to cleave at up to nine highly conserved HIV-1 env RNA regions inhibits HIV-1 replication—potential effectiveness against most presently sequenced HIV-1 isolates. Nucleic Acids Research. 20(17). 4581–4589. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026